⌘K

Login Start Free

U.S. Stem Cell, Inc.·4

Jul 23, 4:02 PM ET

Knutson Gregory 4

4 · U.S. Stem Cell, Inc. · Filed Jul 23, 2021

Insider Transaction Report

Form 4

Period: 2020-04-01

U.S. Stem Cell, Inc.USRM

Knutson Gregory

Director

Transactions

Other
Common Stock
2020-10-05$0.00/sh+2,035,820$9,161→ 35,286,969 total(indirect: By LLC)
Other
Common Stock
2020-04-01$0.01/sh+1,445,647$8,674→ 32,251,149 total(indirect: By LLC)
Other
Common Stock
2021-04-02$0.05/sh+187,575$9,135→ 35,474,544 total(indirect: By LLC)
Award
Convertible promissory Note (right to buy)
2021-02-17$100000.00/sh+3,759,398$375,939,800,000→ 7,384,398 total
Exercise: $0.03From: 2021-02-17Exp: 2022-02-17→ Common Stock (3,759,398 underlying)

Holdings

Common Stock
1,675,000

Footnotes (1)

[F1]Interest payment on outstanding debt.

Documents

1 file

4
ownership.xmlPrimary